Study of Topical SOR007 Ointment for Cutaneous Metastases

NCT03101358 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Metastasis

Interventions

DRUG: SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment

Sponsor

NanOlogy, LLC

Collaborators

[object Object]